LATEST NEWS

A Phase I Study of NBTXR3 Activated by Radiotherapy for Patients with Advanced Cancers Treated With an Anti-PD-1 Therapy

For inquiries about our technology, collaborations, clinical trials, or other topics, we encourage you to get in touch with our team.